Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
Opravil M, Perrin L, Ledergerber B, Vernazza P, Blasko M, Bernasconi E, Calmy A, Furrer H, Chave J, Baumann D, Swiss HIV Cohort Study. Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine. AIDS (London, England) 2004; 18:2213-5.
05.11.2004
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
05.11.2004
AIDS (London, England) 2004; 18:2213-5
Opravil Milos, Perrin Luc, Ledergerber Bruno, Vernazza Pietro, Blasko Monika, Bernasconi Enos, Calmy Alexandra, Furrer Hansjakob, Chave Jean-Philippe, Baumann Doris, Swiss HIV Cohort Study
Weiter
